Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00302627 · ClinicalTrials.gov registry record · NA
Pamidronate, Vitamin D, and Calcium for the Bone Disease of Kidney and Heart Transplantation
A NA study, sponsored by Providence Health & Services.
- Completed
- Registry status
- NA
- Development phase
- 43
- Enrollment target
NCT00302627 is a NA study that has completed, run by Providence Health & Services. The registered enrollment target is 43 participants.
The verdict
NCT00302627, a NA study, has completed, sponsored by Providence Health & Services.
- COMPLETED
- Registry status
- NA
- Development phase
- 43 participants
- Enrollment target
Study Summary
Bone is lost rapidly and fractures occur in 10-20% of patients who receive organ transplants within 2 years. The purpose of this study is to evaluate long-term effects of a pamidronate-vitamin D-calcium regimen on bone loss, fractures, and safety in recipients of kidney and heart transplants.
Interventions
- DRUG Pamidronate
- DRUG Calcium Carbonate
- DRUG vitamin D
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 1999-01 |
| Est. Completion | 2002-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00302627
The ClinicalTrials.gov registry entry for NCT00302627 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Providence Health & Services, which has 69 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Pamidronate is the first listed.
NCT00302627 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00302627 about?
NCT00302627 is a clinical study titled "Pamidronate, Vitamin D, and Calcium for the Bone Disease of Kidney and Heart Transplantation". Bone is lost rapidly and fractures occur in 10-20% of patients who receive organ transplants within 2 years. The purpose of this study is to evaluate long-term effects of a pamidronate-vitamin D-calcium regimen on bone loss, fractures, and safety in recipients of kidney and heart transplants.
What is the current status of trial NCT00302627?
This trial is currently completed. It is a NA study. The enrollment target is 43 participants. The study started on 1999-01. Estimated completion is 2002-11.
What interventions are being tested in trial NCT00302627?
The interventions under investigation include: Pamidronate (DRUG), Calcium Carbonate (DRUG), vitamin D (DRUG).
Who is sponsoring clinical trial NCT00302627?
This trial is sponsored by Providence Health & Services, which has 69 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.